• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Americas Insomnia Market Share

    ID: MRFR/Pharma/0126-HCR
    50 Pages
    Rahul Gotadki
    October 2025

    Americas Insomnia Market Research Report, by types of therapy (Pharmacological therapy and Non Pharmacological therapy), by drug formulation (Capsules, Tablet and others), by type of disease (poor quality of sleep, sleep maintenance and others)- Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Americas Insomnia Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Americas Insomnia Market Share Analysis

    The Americas Insomnia market, a pivotal domain within the sleep disorders arena, demands unwavering strategic prowess to conquer its complexities. Successfully positioning in this realm requires resolute determination to address the pervasive issue of insomnia, which affects countless lives across the Americas. Holding market position initiation is contemplated through a determination of population. The various types of humans' sleep patterns and special lifestyle factors of various age groups, areas and social positions drill that one understand well in order to design particular strategies that fit each person who is fighting against insomnia. However, no matter how unforgiving the chase, using cutting edge technology is not just an option but a requirement as well. The quest for innovative and breakthrough American insomnia market healthcare solutions and drugs is the never-ending pursuit of therapeutics that the latter market is creating. Businesses have to determine strictly on the R&D towards the surge of the wave of inventions that goes beyond the basal rules of drugs industry, and these are what offers a relief to persons suffering from insomnia. Roughly plying the roads of Americas insomnia market means that companies need to build unsinkable partnerships with health care giants. Collaboration with well-known medical institutions, sleep clinics, and pharmaceutical powerhouses cannot be viewed simply as a strategically chosen path, rather it is an environmental command. Such agreements will no doubt form the foundation for the imminent spread of innovative insomnia relief and for the overall hold in the market. One of the unquestionable solidities that we will never waver from is implementing standard compliance which is not an aspect to be debated but one we will never concede to. Companies should be able to defend a stand and they should be working the health bodies regulations that will make their insomnia solutions to meet up the laid down rules. Reputation is the armor which is constructed of strict observance of compliance rules and it gives the protection that is needed when the uncertain factors are met. Such a scenario calls for a multifaceted marketing campaign, which must transcend the realm of traditional advertising. It should replace it with an educational campaign. Companies must be willing put all their attention into creating and distributing educational materials that explain a clear way to get good, quality sleep. The sharing of knowledge in the form of seminars , educational materials , and digital platforms is not optional.It is the considering to persuade and gain trust with the individuals . In terms of the global leadership precisely, a Pan-American outreach is required to achieve the domination eventuality. While on one hand, it should not be a generalised way; on the other hand, it requires capturing cultural nuances that shape the rhythm of the sleep. By meeting the needs of millions of insomnia sufferers who are from different cultures and addressing their needs through personalized solutions, we prove it is not just loud resonance but the harmonious resonance too. The campaign does not end with the launch; it extends into the post-market realm. Establishing robust surveillance mechanisms is not a choice; it is a shield against uncertainties. Real-world data and patient experiences are not just metrics; they are the compass guiding the journey toward perpetual improvement and market ascendancy. In this unwavering campaign, inspiration is not a byproduct; it is the driving force. Through unshakable confidence, resolute determination, and unyielding fortitude, companies can inspire a deep sense of assurance in the market. In the Americas Insomnia arena, there is no room for hesitation or vacillation—only the bold, the certain, and the unassailable shall emerge triumphant.

    Market Summary

    The United States insomnia market is projected to grow from 2.43 USD billion in 2024 to 4.12 USD billion by 2035.

    Key Market Trends & Highlights

    Americas Insomnia Key Trends and Highlights

    • The insomnia market in the United States is expected to experience a compound annual growth rate of 5.34 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 4.31 USD billion, indicating robust growth potential.
    • in 2024, the market is valued at 2.43 USD billion, reflecting the current demand for insomnia solutions.
    • Growing adoption of innovative sleep therapies due to increasing awareness of mental health is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.43 (USD Billion)
    2035 Market Size 4.12 (USD Billion)
    CAGR (2025-2035) 4.92%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Eisai, Co. (Japan), Pfizer, Inc. (US), Merck & Co Inc (US), Sanofi (France), Takeda Pharmaceutical Company (Japan), Meda Consumer Healthcare Inc (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Flynn Pharma (UK), Johnson & Johnson (US), Astellas (UK), Biocodex S A (France), Neurim (Switzerland), SkyePharma (UK), Vanda Pharmaceuticals Inc. (US)

    Market Trends

    Americas Insomnia Market Market Drivers

    Market Segment Insights

    Regional Insights

    Key Companies in the Americas Insomnia Market market include

    Industry Developments

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2024 USD 2.43 billion
    Market Size 2035 4.12 (Value (USD Billion))
    Compound Annual Growth Rate (CAGR) 4.92% (2025 - 2035)
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019- 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Growth Factors, Market Competitive Landscape, and Trends
    Segments Covered Types Of Therapy, Drug Formulation, Type Of Diseases Condition and Region
    Geographies Covered North America
    Countries Covered U.S, Canada
    Key Companies Profiled Eisai, Co. (Japan), Pfizer, Inc. (US), Merck & Co Inc (US), Sanofi (France), Takeda Pharmaceutical Company (Japan),  Meda Consumer Healthcare Inc (US), Pernix Therapeutics (US), Purdue Pharma L.P. (US), Consumer Healthcare Inc. (Canada), Dainippon Sumitomo (Japan), ECR Pharmaceuticals (US), Flynn Pharma (UK), Johnson & Johnson (US),  Astellas (UK), Biocodex S A (France), Neurim (Switzerland), SkyePharma (UK), and Vanda Pharmaceuticals Inc. (US). 
    Key Market Opportunities Increasing awareness of sleep disorders, and changing lifestyle patterns
    Key Market Dynamics Increasing prevalence of insomnia among the population
    Market Size 2025 2.55 (Value (USD Billion))

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Table of Contents
    2. 1    INTRODUCTION    
      1.     DEFINITION    
      2.     SCOPE OF STUDY    
        1.     RESEARCH OBJECTIVE    
        2.     ASSUMPTIONS & LIMITATIONS    
      3.     MARKET STRUCTURE:    
    3. 2    Research Methodology    
      1.     RESEARCH PROCESS:    
      2.     PRIMARY RESEARCH    
      3.     SECONDARY RESEARCH:    
    4. 3    MARKET DYNAMICS    
      1.     DRIVERS    
      2.     RESTRAINTS        
      3.     OPPORTUNITIES    
      4.     MACROECONOMIC INDICATORS    
    5. 4    MARKET FACTOR ANALYSIS    
      1.     PORTERS FIVE FORCES MODEL    
      2.     BARGAINING POWER OF SUPPLIERS    
      3.     BARGAINING POWER OF BUYERS    
      4.     THREAT OF NEW ENTRANTS    
      5.     THREAT OF SUBSTITUTES    
      6.     INTENSITY OF RIVALRY    
    6.     AMERICAS INSOMNIA MARKET, BY TYPES OF THERAPY 
      1.     PHARMACOLOGICAL THERAPY 
        1.     BENZODIAZEPINES
        2.     NON-BENZODIAZEPINES
        3.     MELATONIN RECEPTOR AGONISTS 
        4.     OTHER
      2.     NON PHARMACOLOGICAL THERAPY 
        1.     RELAXATION THERAPY
        2.     COGNITIVE BEHAVIORAL THERAPY
        3.     SLEEP HYGIENE EDUCATION
        4.     STIMULUS CONTRO
        5.     PARADOXICAL INTENTION 
        6.     OTHER
    7.     AMERICAS INSOMNIA MARKET, BY DRUG FORMULATION 
      1.     CAPSULES
      2.     TABLET 
      3.     OTHERS.
    8.     AMERICAS INSOMNIA MARKET, BY TYPES OF DISEASE
      1.     POOR QUALITY OF SLEEP
      2.     SLEEP MAINTENANCE 
      3.     OTHER.
    9.     AMERICAS INSOMNIA MARKET, BY REGION
      1.     INTRODUCTION
      2.     NORTH AMERICA
        1.     US
        2.     Canada
        3.     SOUTH AMERICA
    10.     Competitive Landscape    
      1.     MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS    
        1.     STRATEGIC PARTNERSHIP    
        2.     MERGER & ACQUISITION    
    11. 10    COMPANY PROFILE    
      1.     EISAI, CO.
        1.     OVERVIEW    
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      2.     MERCK & CO INC
        1.     OVERVIEW    
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      3.     SANOFI
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS
        4.     STRATEGY    
        5.     KEY DEVELOPMENT    
      4.     TAKEDA PHARMACEUTICAL COMPANY
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW
        3.     FINANCIALS
        4.     KEY DEVELOPMENTS    
      5.     PFIZER, INC.
        1.     OVERVIEW
        2.     PRODUCT OVERVIEW    
        3.     FINANCIALS    
        4.     KEY DEVELOPMENTS    
      6.     OTHERS

    Americas Insomnia Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials